Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.86
BATS BZX Real-Time Price
As of 3:35pm ET
 -0.13 / -1.63%
Today’s Change
7.12
Today|||52-Week Range
11.63
-11.29%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close7.99
Today’s open8.07
Day’s range7.86 - 8.08
Volume31,700
Average volume (3 months)378,559
Market cap$642.5M
Data as of 3:35pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)-20.74%
Earnings growth (next 5 years)+29.70%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.43+3.87%
KANGiKang Healthcare Gro...+0.14+0.88%
ENZEnzo Biochem Inc+0.08+1.01%
GHDXGenomic Health Inc+0.84+2.48%
Data as of 3:21pm ET, 01/22/2018

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts